Editor-in-Chief: Godefridus J. Peters
Journal Rank: Impact Factor 2024: 5.2 - Q1 (ONCOLOGY); CiteScore 2024: 8.3 - Q1 [Pharmacology(medical)]
Median time to first editorial decision: 9 days

Cancer Drug Resistance

Articles

Most Recent | Most Viewed | Most Downloaded

TROP2-targeting antibody–drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms

Open Access Review DOI: 10.20517/cdr.2025.195 25 Feb 2026
Views: Downloads:
Download PDF

Evaluation of intracellular nucleotide pools in peripheral blood and bone marrow mononuclear cells and their association with frontline intensive chemotherapy response rates in AML patients

Open Access Original Article DOI: 10.20517/cdr.2025.191 13 Feb 2026
Views: Downloads:
Download PDF

Extracellular vesicles shed by multidrug resistant cells contribute to the identification of SRC inhibitors as chemosensitizers in non-small cell lung cancer

Open Access Original Article DOI: 10.20517/cdr.2025.175 10 Feb 2026
Views: Downloads:
Download PDF

Novel anti-tumor strategies: targeting the crosstalk between cancer stem cells and cancer-associated fibroblasts to resist drug resistance

Open Access Review DOI: 10.20517/cdr.2025.189 20 Jan 2026
Views: Downloads:
Download PDF

Identification of antibody-drug conjugate payloads that are substrates of ATP-binding cassette drug efflux transporters

Open Access Original Article DOI: 10.20517/cdr.2025.151 12 Jan 2026
Views: Downloads:
Download PDF

Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment

Open Access Review DOI: 10.20517/cdr.2024.152 6 Jan 2025
Views: Downloads:
Download PDF

NFE2L2 and ferroptosis resistance in cancer therapy

Open Access Review DOI: 10.20517/cdr.2024.123 24 Oct 2024
Views: Downloads:
Download PDF

Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer

Open Access Review DOI: 10.20517/cdr.2024.06 2 Jun 2024
Views: Downloads:
Download PDF

Overcoming Mechanisms of Therapeutic Resistance in Pancreatic Cancer

Submission Deadline: 31 Aug 2026

Published articles: 0

Integrating Multi-Omics and Artificial Intelligence in Deciphering Cancer Drug Resistance

Submission Deadline: 31 Jul 2026

Published articles: 0

Coming soon.

For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Articles Collection
Exploring the Future of Cancer Immunotherapy, the Impact of Treg Cell Discovery, and Ethical Considerations in CRISPR Research
Prestigious Honor, Global Impact: 58 CDR Editorial Board Members Ranked Among World's Top 2% Scientists, Reinforcing the Journal's Leadership in the Field
Advancing the Fight Against Cancer Drug Resistance Together: Share Your Findings and Enjoy Anniversary Savings!
Marking a 13% rise, CDR continues to lead the field of cancer drug resistance.
This marks a notable 25.8% increase from last year's score of 6.6, underscoring the CDR's rising academic impact and global recognition.

Overcoming Mechanisms of Therapeutic Resistance in Pancreatic Cancer

Submission Deadline: 31 Aug 2026

Published articles: 0

Integrating Multi-Omics and Artificial Intelligence in Deciphering Cancer Drug Resistance

Submission Deadline: 31 Jul 2026

Published articles: 0

Coming soon.

Articles Collection
Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/